Washington Manual of Medical Therapeutics
- AASLD Treatment Guidelines for Chronic Hepatitis B
- Activity of Novel Gram-Negative Antibiotics versus Resistant Organisms
- Acute Gout Treatment
- Acute Leukemias With Recurrent Genetic Abnormalities
- American College of Cardiology/American Heart Association Guidelines of Evaluation and Management of Chronic Heart Failure in Adults
- Anaphylaxis
- Annual Stroke Risk in Patients With Nonvalvular Atrial Fibrillation Not Treated With Anticoagulation According to the CHA2DS2-VASc Score
- Anticoagulant Medications
- Anticoagulants for Treatment of Venous Thromboembolism (VTE)
- Antiplatelet Agents in UA/NSTEMI
- APE2 Score
- Appropriate Selection of Routine Invasive Versus Ischemia-Driven Revascularization Strategy in Patients With NSTEMI/UA
- Approximate Kinetics of Insulin Preparations
- Assessment of Asthma Control
- Assessment of the Probability of Malignancy
- Biologic DMARDs
- β-Blockers Commonly Used for Ischemic Heart Disease
- Body Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index
- Calcineurin Inhibitors
- Calcium Channel Blockers Commonly Used for Ischemic Heart Disease
- Canadian Cardiovascular Society (CCS) Classification System
- Causes of Acute Renal Failure
- Causes of Acute Spinal Cord Dysfunction
- Causes of Altered Mental Status
- Causes of Bradycardia
- Causes of Eosinophilia
- Causes of Pleural Effusion
- Causes of Shunt
- Chronic Lymphocytic Leukemia Clinical Staging
- Chronic Obstructive Pulmonary Disease Assessment Tool (CAT)
- Classification of Asthma Exacerbation Severity
- Classification of Asthma Severity on Initial Assessment
- Classification of Blood Pressure for Adults Age 18 Years and Oldera
- Classification of Eosinophilia Based on the Peripheral Blood Eosinophil Count
- Classification of Severity of Airflow Limitation in Chronic Obstructive Pulmonary Disease (Based on Postbronchodilator FEV1)
- Classification of Thrombocytopenia
- Clinical and Epidemiologic Features of Hepatotropic Viruses
- Clinical and Radiologic Features of Interstitial Lung Diseases
- Clinical Classification of Pulmonary Hypertension: Dana Point (2008) Classification System of Pulmonary Hypertension
- Commonly Used Antiarrhythmic Drugs
- Commonly Used Antiemetics
- Commonly Used Antihypertensive Agents by Functional Class
- Commonly Used Parenteral Solutions
- Commonly Used Sedation Medications in the Intensive Care Unit
- Common Vagal Maneuvers and Adenosine
- Comparative Daily Adult Dosages for Inhaled Corticosteroids
- Conditions That Can Present as Refractory Asthma
- Conditions That May Provoke or Exacerbate Ischemia/Angina Independent of Worsening Atherosclerosis
- Contraindications to Thrombolytic Therapy
- Criteria for Defining an Effusion
- Criteria for ST-Segment Elevation for Prior LBBB or RV-Paced Rhythm
- Currently FDA-Approved CFTR Modulators
- Cytogenetic Abnormalities in Acute Myeloid Leukemia and Associated Prognosis
- Definition of Infective Endocarditis (IE) by Modified Duke Criteria
- Diagnosis of Diabetes
- Diagnostic Accuracy of Common Stress Testing Modalities in Patients Without Known Ischemic Heart Disease
- Diagnostic Criteria of HRS-AKI
- Differential Diagnosis of Acute Immune Demyelinating Polyneuropathy
- Differential Diagnosis of Alzheimer Dementia
- Differential Diagnosis of Chest Pain Excluding Epicardial Atherosclerosis
- Differential Diagnosis of Hyperthyroidism
- Differential Diagnosis of Major Lipid Abnormalities
- Differential Diagnosis of Parkinson Disease
- Differential Diagnosis of Renal Allograft Dysfunction
- Differential Diagnosis of ST-Segment Elevation on ECG Excluding STEMI
- Differential Diagnosis of the Solitary Pulmonary Nodule (SPN)
- Disease-Modifying Therapies Approved for Use in Relapsing-Remitting Multiple Sclerosis
- Distinguishing Manifestations
- Dosing Examples for Urinary Tract Infections
- Dosing of N-Acetylcysteine
- Drugs Commonly Used for Treatment of Heart Failure
- Drugs to Facilitate Endotracheal Intubation
- Eastern Cooperative Oncology Group (ECOG) and Karnofsky Score
- Effects of Drugs on Thyroid Function Tests
- Effects of Selected Antipsychotics
- Electrocardiogram-Based Anatomic Distribution
- Electrolyte Concentrations in Gastrointestinal Fluids
- Emerging Infectious Diseases
- Empiric Therapy Examples for Intra-Abdominal Infections
- Empiric Therapy for Urinary Tract Infections
- Empiric Treatment for Community-Acquired Pneumonia
- Endocarditis Prophylaxis
- Enteral Feeding Formulas: Comparing Composition
- Epidemiology of Hemoptysis
- Equipotent Doses of Opioid Analgesics
- Erythropoietin Dosing
- Estimated Energy Requirements for Hospitalized Patients Based on Body Mass Index
- Estimated New Cancer Cases and Rates of Death for Most Common Cancer Diagnoses in the US for
- Etiologies of Seizures
- Etiology of Hemoptysis
- European Society of Cardiology Mortality Risk Classification of Patients Who Have Acute Pulmonary Embolism
- Exercise Stress Testing: Duke Treadmill Score
- Expected Compensatory Responses to Primary Acid-Base Disorders
- Factor Deficiencies That Cause Prolonged Prothrombin Time and/or Activated Partial Thromboplastin Time and Correct With 50:50 Mix
- FDA-Approved Biologics for Asthma
- Fibrinolytic Agents
- Forrest Classification of Peptic Ulcers
- Guidelines for Vitamin and Mineral Supplementation in Patients with Severe Malabsorption
- Healthcare Isolation Recommendations for Specific Infections
- Heart Failure Etiology
- Helpful Features of Exudative Pleural Effusions
- Hemodynamic Patterns Associated With Specific Shock States
- Immunologically Mediated Drug Reactions
- Inclusion and Exclusion Criteria for Endovascular Thrombectomy (Washington University Stroke Center Protocol)
- Inclusion and Exclusion Criteria for t-PA for Acute Ischemic Stroke (Washington University Stroke Center Protocol)
- Indications and Contraindications for Noninvasive Ventilation in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
- Indications for Invasive Mechanical Ventilation in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
- Indications for Vancomycin Use
- Inhaler Pharmacotherapy for Chronic Asthma and Chronic Obstructive Pulmonary Diseasea
- Inotropic/Sympathomimetic Agentsa
- International Society on Thrombosis and Haemostasis Disseminated Intravascular Coagulation Scoring System
- IV Iron Preparations
- Killip Classification
- King's College Criteria
- Laboratory Findings in Oliguric Acute Kidney Injury
- Lifestyle Modifications and Effects
- List of Selected Familial Cancer Syndromes With High Penetrance
- Lugano Staging of Lymphomasa
- Major Causes of Hyperprolactinemia
- Major Mineral Daily Requirements, Deficiency, Toxicity, and Diagnostic Evaluation
- Mallampati Airway Classification
- Manifestations of Target Organ Disease
- Medical Treatment of Selected Interstitial Lung Diseases
- Medications for Inflammatory Bowel Disease
- Medications for Opioid Use Disorder
- Modified Duke Criteria for the Diagnosis of Infective Endocarditis
- Myositis-Specific Antibodies (MSA)
- New York Heart Association (NYHA) Functional Classification
- Nitrate Preparations Commonly Used for Ischemic Heart Disease
- Nomenclature
- Noninsulin Medications for Diabetes
- Nutrient Composition of the Therapeutic Lifestyle Change Diet
- Oncologic Emergencies
- Opportunistic Infection Prophylaxis
- Oral Iron Preparations
- Other Anticonvulsants
- Other Antihypertensives
- Other Sedatives
- Parenteral Antihypertensive Drug Preparations
- Pharmacologic Agents Used for Heart Rate Control in Atrial Fibrillation
- Pharmacotherapy for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
- Pharmacotherapy for Smoking Cessation
- Physical Properties of Plasma Lipoproteinsa
- Pretest Probability of Coronary Artery Disease by Age, Gender, and Symptoms
- Procedure for Endotracheal Intubation, Needle Cricothyrotomy, and Cricothyrotomy
- Rabies Postexposure Prophylaxis Recommendations
- Recommended Daily Protein Intake
- Refined ABCD Assessment Tool for Chronic Obstructive Lung Disease
- Regimens Used for Eradication of Helicobacter pylori
- Review of Major Genetic Dyslipoproteinemias
- Revised International Prognostic Scoring System (IPSS-R) for Myelodysplastic Syndromes
- Revised-International Staging System and Risk Stratification in Myeloma
- Scadding Staging of Sarcoidosis
- Secondary Stroke Prevention (“BLASTED”)
- Select Chromosomal Abnormalities in B-Cell Non-Hodgkin Lymphomas
- Selected Adult Immunization Recommendations in the United States
- Selected Adult Postexposure Prophylaxis Recommendations
- Selected Postexposure Guidelines for Healthcare Personnela
- Sensitivity of ANCA Antibodies
- Statin Therapy Regimens by Intensity
- Summary of Selected Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 Criteria
- Symptoms Associated With Obstructive Sleep Apnea-Hypopnea Syndrome
- Synovial Fluid Analysis
- Synthetic DMARDs
- Thalassemias
- The Four Primary Acid-Base Disorders and Their Common Etiologies
- Timing and Etiology of Posttransplant Infections
- Toxidromes
- Trace Minerals, Fat-Soluble Vitamins, and Water-Soluble Vitamins: Recommended Daily Intake, Deficiency, At-Risk Populations, Toxicity, and Status Evaluation
- Treatment of Common Pathogens Associated With Bloodstream Infections and Catheter-Related Bloodstream Infections
- Treatment of Common Supraventricular Tachyarrhythmias
- Treatment of Diabetic Ketoacidosis
- Treatment of Endocarditis Caused by Specific Organisms
- Treatment of Fungal Infections, Nocardia, and Actinomyces
- Treatment of Hyperosmolar Hyperglycemic State
- Treatment of Osteomyelitis
- Treatment of Sexually Transmitted Infections
- Treatment of Toxic Shock Syndromes
- 4T Scoring System for Pretest Probability of Heparin-Induced Thrombocytopenia
- Typical Cerebrospinal Fluid Findings in Meningitis
- Upstream Medical Therapy
- Urate-Lowering Therapies
- Use of Hepatitis B Virus (HBV) Markers in Clinical Practice
- Validated Risk Assessment Tools in PAH
- Vasculitis Classification
- Vasculitis Features by Vessel Size
- Vasomodulator/Vasodilatory Therapy for Pulmonary Arterial Hypertension
- Viral Hepatitis Serologiesa
- WHO 2016 Diagnostic Criteria for Polycythemia Vera
- WHO 2016 Diagnostic Criteria for Primary Myelofibrosis (PMF)